We’ve got a new pitch from Jason Stutman’s Techology & Opportunity to take a gander at, and it’s another of those “three parters” that pitches a few different stocks as a play on a theme… so I’m going to try to be economical with the verbiage and get to all of ’em before you lose […]
Everybody looooves IPOs, they bring with them the allure of “getting in early” and being a special first-mover who can brag about “buying the future” … so it’s not unusual to see newsletters teased because they have some secret idea for “getting in the back door” or buying BEFORE an IPO, but this new IPO […]
Entry level newsletter that promises monthly IPO picks and general updates on the IPO market.
Everyone hates their cable company and their wireless company. When we used to have home phones, we hated Ma Bell, too… everyone who has a monopoly or near-monopoly and uses that to keep prices and profits high and customer service low gets ranked pretty far up the “hate” list, whether its the airlines or the […]
We’ll start the week out with a teaser pitch I’ve been seeing from Jason Stutman for his Technology & Opportunity newsletter. As with so many stocks that are hinted at, this one plucks at our greed-strings via comparison with a massive success story — this time it’s Netflix, as Stutman refers to his “secret” pick […]
Jason Stutman’s “upgrade” newsletter, The Cutting Edge ($1,499/yr), is out with a teaser campaign that promises you the chance at riches from “Charged Ore” … and, in fact, an actual sample of that ore itself as part of your subscription. So what is “Charged Ore,” and what’s this little Nebraska mine that Stutman thinks will […]
Jason Stutman has a teaser pitch going around for his Technology & Opportunity newsletter (currently $99), and the bait for us is that he’s promising a company that will get you rich as Monsanto dies. Lots of folks have a deep hatred for Monsanto, of course, both because of anti-GMO fear and Roundup resistance/overuse/drift/cancer risk […]
Today we’ve got another pitch from Jason Stutman to decipher… and it’s actually fairly similar to a teaser ad he was circulating a year or two ago, though the company being hinted at this time is different. The ad is for The Cutting Edge, which will run you $1,499/yr. As with his teaser pitch last […]
This is a pitch from Jason Stutman’s The Cutting Edge newsletter, his higher-end service from Angel Publishing (about $1,500/year), and what caught my eye was the headline promise that Harvard University is “calling for a 29,000% surge for one tiny company you’ve never heard of.” So what is it? Well, it’s appropriate that we’re looking […]
This article, originally titled “‘Universal Voice Control’ and ‘The End of Google as We Know it,’” was published on May 11. The ads have recently been coming in hot and heavy for this service, with the new ads headlined “Want to Invest like Jeff Bezos” and “Jeff Bezos’ Next Big Bet”, so we’re re-running this […]
Today we’ve got a teaser that has already been solved, and it’s for a teensy weensy stock that has already experienced a dramatic surge in its fortunes over the past week or so just because a large publisher teased the stock… so you can probably predict that my sentiment is likely to be something along […]
This teaser solution first appeared as part of a Friday File that was sent to the Irregulars on January 15, 2016, so it just passed its first birthday… but so many readers are asking about it again now that we’re re-posting it for everyone to read. What follows has not been updated or revised since […]
The latest pitch from Jason Stutman for his Technology & Opportunity newsletter is all about the big changes happening in the auto industry — primarily the safety and self-driving innovations that are driving auto tech forward. The intro is, of course, much more attention-getting than my first paragraph above — this is how the ad […]
I expect most investors would be pleased to write off the past 15 days and start the year over at this point, but life goes on — we buy when things look attractive, we sell when we think they look unattractive or we realize we made a mistake, and we limit the sorrow when we’re […]
Every year, I scroll through the last twelve months or so of teaser picks and look for one that really stands out as the stinker of the bunch, to be called the Turkey of the Year and hold that place of honor at Thanksgiving time. Hopefully, we can all give thanks that we didn’t own […]
Newsletter marketers love to be able to tout a buyout and promise a double in the stock they’re recommending — they know it almost can’t help but catch your attention… and heck, if the stock’s small enough they might even be able to cause it to double just by pouring a few hundred enthused new […]
Jason Stutman’s tech-focused trading advisory that tries to find breakthrough technology opportunities when stocks are oversold and, he thinks, ready to surge.
I’ve got a few stocks to mention in the medical space this week — one to update that’s in my portfolio, one to confirm as a teaser pick (since folks keep asking) after several Gumshoe readers discussed it last week, and one to note as a teaser idea that’s being pushed pretty heavily (though the […]
Christian DeHaemer launched a newsletter called Technology & Opportunity about a year and a half ago, piquing investors’ interest with the idea that you can “Ride the Robot Revolution” and make massive gains, just like getting in early on the computer revolution by buying Apple, Microsoft or Dell 30 years ago. And now it looks […]
Comments
No, neither one was particularly interesting to me the first time around and I haven't followed them closely. Looks lik...
Has anyone figured out the 3 5g stocks and several others being touted by Jason Stutman at Angel publishing which...
We covered that one here: https://www.stockgumshoe.com/reviews/cutting-edge-the/whats-being-teased-as-project-iris-the-5...
$CLTX - “A TINY BIOTECH CONTROLS AGRICULTURAL TECHNOLOGY THAT COULD END FOOD SHORTAGES FOREVER… “ https://www.sto...
I suspect you're thinking about the pitch from Jason Stutman for AI and microphones (for Alexa) that I covered here: htt...
This is why you wanted to invest when it was at 6 CENTS “the value of this firm could absolutely explode... as I menti...
What is the name of this tine $0.15 stock Jason Stutman is touting ?...
Jason Stutman, and AR/VR deniers really need to get a grip and do there DD particularly addressing $NVDA :-) Best ~ Ben...
I just want to post heartful thanks to Travis Johnson for this superb article . Just thinking, I had to submit to t...
I agree, sounds like two different ads mixed together. The ad most consistently rolling now that mentions Zuckerberg's ...
Yes, this Nicholas Vardy one is from 2011 -- the Jason Stutman one you're asking about teased Himax, we covered it here ...
Just received an email on the iPhone Killer entitled "The Death of the iPhone". Written by Jason Stutman the blog states...
Sharon, thx. ZKSS sometimes drives by unintentionally (my opinion) and also desires us to think on our own. He is a Gr...
frankw17 say: January 9, 2016 at 3:36 pm Dr. KSS, Jason Stutman wrote an article “Biotech’s next $40 billion mar...
Dr. KSS, Jason Stutman wrote an article "Biotech's next $40 billion market" in "Wealth Daily" re. a very small compan...
Thanks Travis for all your fantsdtic research throughtout 2015. I have just been invited to subscribe to 3 robotics comp...
That one was from Jason Stutman, he says he heard it from a friend in Vancouver and it made the hair on his neck stand u...
This is really good stuff. Travis doing his thing, Mr. Jason Stutman coming public and explaining his opinion on his add...
A tease from Tech Investing Daily that may be of interest to the Gummunity :-) Outdated tech threatens U.S. military B...
Regarding another biotech company, Jason Stutman has started touting around his Technology and Opprotunity service, as t...
TRIL,AUPH,AKAO and others -More dangerous than heroin (it's not what you think) By Jason Stutman | Thursday, April 2nd, ...
I am posting this as a reminder of the extreme value that stockgumshoe.com and the amazing group of irregulars provide...